<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45138">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01794026</url>
  </required_header>
  <id_info>
    <org_study_id>DWMRIGASTADENO</org_study_id>
    <nct_id>NCT01794026</nct_id>
  </id_info>
  <brief_title>Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma Patients</brief_title>
  <official_title>Use of Diffusion Weighted Magnetic Resonance Imaging to Stage Gastric Adenocarcinoma Patients Preoperatively</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <authority>Turkey: Bezmialem Vakif University Faculty of Medicine</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative staging for gastric adenocarcinoma is an important procedure to detect advanced
      disease stateS for the patients in which the surgery may be unnecessary to perform. Although
      there are many imaging techniques for this purpose, sensitivity and specificity of these
      techniques still remains to be low.Preoperative detection of peritoneal carcinomatosis and
      involvement of lymph nodes beyond D2 may prevent surgical procedures.

      Removal of the determined lymph nodes according to the type of the surgery is the accepted
      surgical method. However, accurate determination of malignant lymph nodes may prevent
      dissection of some groups of the lymph nodes. These findings may cause a new definition of
      gastric lymph node dissection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. proven endoscopic diagnosis of gastric adenocarcinoma

        2. for staging purposes, computed tomography for all patients

        3. evaluation of benign and malignant lymph nodes according to computed tomography
           findings and mapping of the lymph nodes

        4. to state precisely resectable patients according to computed tomography and anesthetic
           evaluation

        5. evaluation of benign and malignant lymph nodes according to diffusion weighted magnetic
           resonance imaging findings and mapping of the lymph nodes

        6. standard gastrectomy and D2 lymph node dissection

        7. mapping of the lymph nodes after taking the specimen out

        8. histopathological diagnosis of the lymph nodes and mapping

        9. comparison of the results taken from computed tomography, diffusion weighted magnetic
           resonance imaging and histopathological analysis
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>efficacy of diffusion weighted magnetic resonance imaging to detect benign and malignant lymph nodes</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>to compare the radiologic diagnosis of benign and malignant lymph nodes with histopathological diagnosis</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Gastric Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>diffusion MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>histopathology of lymph nodes diagnosed by diffusion weighted magnetic resonance imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>diffusion weighted magnetic resonance imaging</intervention_name>
    <description>for diagnostic purposes, diffusion weighted magnetic resonance imaging in all patients</description>
    <arm_group_label>diffusion MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gastric adenocarcinoma proven by endoscopic biopsy;

          -  application of both computed tomography and diffusion weighted magnetic resonance
             imaging;

          -  standard gastrectomy and a D2 lymph node dissection;

          -  desire to attend the study protocol

        Exclusion Criteria:

          -  preoperative neoadjuvant therapy;

          -  metastatic disease;

          -  undesired reaction to attend the study protocol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University Faculty of Medicine Dept of General Surgery</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 31, 2013</lastchanged_date>
  <firstreceived_date>February 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diffusion weighted</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>surgery</keyword>
  <keyword>histopathology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
